Ovarian reserve markers in women using various hormonal contraceptives

References

• Skovlund CW, Mørch LS, Kessing LV, et al. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73:1154–1162.
   PubMed Web of Science ®Google Scholar
• Skiba MA, Islam RM, Bell RJ, et al. Hormonal contraceptive use in Australian women: who is using what? Aust N Z J Obstet Gynaecol. 2019;59:717–724.
   PubMed Web of Science ®Google Scholar
• Schmidt L, Sobotka T, Bentzen JG, et al. Demographic and medical consequences of the postponement of parenthood. Hum Reprod Update. 2012;18:29–43.
   PubMed Web of Science ®Google Scholar
• Hvidman HW, Petersen KB, Larsen EC, et al. Individual fertility assessment and pro-fertility counselling; should this be offered to women and men of reproductive age? Hum Reprod. 2015;30:9–15.
   PubMed Web of Science ®Google Scholar
• Landersoe SK, Birch Petersen K, Vassard D, et al. Concerns on future fertility among users and past-users of combined oral contraceptives: a questionnaire survey. Eur J Contracept Reprod Health Care. 2019;24:347–355.
   PubMed Web of Science ®Google Scholar
• Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril. 2011;95:170–175.
   PubMed Web of Science ®Google Scholar
• La Marca A, Sighinolfi G, Radi D, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–130.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, et al. Anti-Müllerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab. 2012;97:1673–1680.
   PubMed Web of Science ®Google Scholar
• Nair S, Slaughter JC, Terry JG, et al. Anti-müllerian hormone (AMH) is associated with natural menopause in a population-based sample: the CARDIA Women’s Study. Maturitas 2015;81:493–498.
   PubMed Web of Science ®Google Scholar
• Depmann M, Eijkemans MJC, Broer SL, et al. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study. Hum Reprod 2016;31:1580–1587.
   Web of Science ®Google Scholar
• Broer SL, Eijkemans MJC, Scheffer GJ, et al. Anti-Müllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96:2532–2539.
   PubMed Web of Science ®Google Scholar
• Birch Petersen K, Hvidman HW, Forman JL, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod. 2015;30:2364–2375.
   PubMed Web of Science ®Google Scholar
• Bentzen JG, Forman JL, Pinborg A, et al. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception. Reprod Biomed Online. 2012;25:612–619.
   PubMed Web of Science ®Google Scholar
• Landersoe SK, Birch Petersen K, Sørensen AL, et al. Ovarian reserve markers after discontinuation of long-term use of combined oral contraceptives. Reprod Biomed Online. DOI:10.1016/j.rbmo.2019.10.004
   Google Scholar
• Kallio S, Puurunen J, Ruokonen A, et al. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil Steril. 2013;99:1305–1310.
   PubMed Web of Science ®Google Scholar
• Birch Petersen K, Maltesen T, Forman JL, et al. The fertility assessment and counseling clinic – does the concept work? A prospective 2-year follow-up study of 519 women. Acta Obstet Gynecol Scand. 2017;96:313–325.
   PubMed Web of Science ®Google Scholar
• Anckaert E, Öktem M, Thies A, et al. Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination. Clin Biochem. 2016;49:260–267.
   PubMed Web of Science ®Google Scholar
• Bentzen JG, Forman JL, Johannsen TH, et al. Ovarian antral follicle subclasses and anti-Müllerian hormone during normal reproductive aging. J Clin Endocrinol Metab. 2013;98:1602–1611.
   PubMed Web of Science ®Google Scholar
• Rosendahl M, Ernst E, Rasmussen PE, et al. True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement. Fertil Steril. 2010;93:995–998.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018.
   Google Scholar
• Li HWR, Wong CYG, Yeung WSB, et al. Serum anti-Müllerian hormone level is not altered in women using hormonal contraceptives. Contraception 2011;83:582–585.
   PubMed Web of Science ®Google Scholar
• Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary–ovarian axis suppression with three oral contraceptive regimens. Contraception 2008;77:162–170.
   PubMed Web of Science ®Google Scholar
• van Heusden AM, Fauser B. Residual ovarian activity during oral steroid contraception. Hum Reprod Update. 2002;8:345–358.
   PubMed Web of Science ®Google Scholar
• van Heusden AM, Fauser B. Activity of the pituitary–ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception 1999;59:237–243.
   PubMed Web of Science ®Google Scholar
• van Heusden AM, Coelingh Bennink HJT, Fauser B. FSH and ovarian response: spontaneous recovery of pituitary–ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives. Clin Endocrinol. 2002;56:509–517.
   PubMed Web of Science ®Google Scholar
• Weenen C, Laven JSE, von Bergh ARM, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77–83.
   PubMed Web of Science ®Google Scholar
• Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19:519–527.
   PubMed Web of Science ®Google Scholar
• Kim-Björklund T, Landgren B, Johannisson E. Morphometric studies of the endometrium, the Fallopian tube and the corpus luteum during contraception with the 300 μg norethisterone (NET) minipill. Contraception 1991;43:459–474.
   PubMed Web of Science ®Google Scholar
• Landgren B-M, Balogh A, Shin MW, et al. Hormonal effects of the 300 μg norethisterone (NET) minipill. Contraception 1980;21:87–113.
   PubMed Web of Science ®Google Scholar
• Endrikat J, Gerlinger C, Richard S, et al. Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide. Contraception 2011;84:549–557.
   PubMed Web of Science ®Google Scholar
• Song S, Chen JK, Lu CH, et al. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol. Contraception 1993;47:527–537.
   PubMed Web of Science ®Google Scholar
• Promedicin.dk. Mini-Pe (norethindrone) [in Danish]. [cited 2019 Sept 2] Available from: http://pro.medicin.dk/Medicin/Praeparater/430.
   Google Scholar
• Kim-Björklund T, Landgren BM, Hamberger L. Is the contraceptive effect of 300 μg of norethisterone mainly peripheral or central?. Contraception 1992;45:57–66.
   PubMed Web of Science ®Google Scholar
• Landgren B-M, Balogh A, Shin MW, et al. Hormonal effects of the 300 μg norethisterone (NET) minipill. II. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration. Contraception 1979;20:585–605.
   PubMed Web of Science ®Google Scholar
• Ulrich ND, Marsch E. Ovarian reserve testing: a review of the options, their applications, and their limitations. Clin Obstet Gynecol. 2019;2:228–237.
   Google Scholar
• Promedicin.dk. Intrauterine contraceptives (progestogens) [in Danish]. [cited 2019 Sep 2] Available from: http://pro.medicin.dk/Laegemiddelgrupper/Grupper/141012#a000
   Google Scholar
• Moraes LG, Marchi NM, Pitoli AC, et al. Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at different times of use. Eur J Contracept Reprod Health Care. 2016;21:318–322.
   PubMed Web of Science ®Google Scholar
• Apter D, Gemzell-Danielsson K, Hauck B, et al. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies. Fertil Steril. 2014;101:1656–1662.
   PubMed Web of Science ®Google Scholar
• Gu Z, Zhu P, Luo H, et al. A morphometric study on the endometrial activity of women before and after one year with LNG-IUD in situ. Contraception 1995;52:57–61.
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. Education and knowledge. Educational attainment (15-69 years), by region, ancestry, highest education completed, age and sex. [cited 2019 Nov 29]. Available from: www.statistikbanken.dk/statbank5a/default.asp?w=1600.
   Google Scholar
• Danish Health Authority. Health of the Danes. Health behaviour. Daily smoking. [cited 2019 Nov 29]. Available from: http://proxy.danskernessundhed.dk/SASVisualAnalyticsViewer/VisualAnalyticsViewer_guest.jsp?reportName=Andel%20der%20ryger%20dagligt&reportPath=/Produktion/Danskernes_Sundhed
   Google Scholar
• Hyldgaard J, Bor P, Ingerslev HJ, et al. Comparison of two different methods for measuring anti-müllerian hormone in a clinical series. Reprod Biol Endocrinol. 2015;13:107.
   PubMed Web of Science ®Google Scholar
• van Helden J, Weiskirchen R. Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay. Hum Reprod. 2015;30:1918–1926.
   PubMed Web of Science ®Google Scholar